Safinamide: A new add-on drug for the treatment of Parkinson's disease

Journal Title: JOURNAL OF MEDICAL COLLEGE CHANDIGARH - Year 2017, Vol 7, Issue 2

Abstract

Safinamide is a new drug approved for the treatment of Parkinson's disease as an add-on therapy for the patients, who are taking levodopa and carbidopa and are experiencing 'off ' episodes. It has multiple modes of action including reversible inhibition of MAO-B enzyme and modulation of glutamate release. The drug increases the 'on' time and reduces the symptoms of Parkinson's disease without producing troublesome dyskinesia.

Authors and Affiliations

Sangeeta Bhanwra, Rajiv Kumar

Keywords

Related Articles

Bleaching as an aesthetic boon to despair society: two case reports

An attractive smile plays a major role in the overall perception of physical attractiveness. In this modern civilized cosmetically conscious world, well contoured and well aligned "white teeth" set a standard for beauty....

Local anesthetic toxicity: etiology, prevention and management

Local anesthetics are the most commonly used drugs in medical and dental setting. In this article we have discussed extensively the etiology of LA toxicity ranging from dose, anesthetic agent, age of patient, possible dr...

Prevalence of Antimicrobial Resistance in Staphylococcus Aureus Isolates to Old and New Antibiotics- A Need for Continued Antimicrobial Surveillance

Background: Accurate antimicrobial susceptibility testing and screening for methicillin resistant S. aureus (MRSA) colonized and infected patients are important tools to limit the spread of this organism. The study evalu...

Ocular Charring from Molten Metal

We report a case of a patient with severe ocular burns due to molten iron while working in a factory. The heat-retaining capacity of the heavy metal, heat of the molten metal at impact and the duration of exposure determ...

Complete Heart Block In H1N1 Infection

H1N1 influenza infection commonly manifests as bilateral bronchopneumonia. Myocarditis of varying severity can also result from influenza. Fulminant myocarditis is a rare complication of viral myocarditis resulting from...

Download PDF file
  • EP ID EP312495
  • DOI -
  • Views 128
  • Downloads 0

How To Cite

Sangeeta Bhanwra, Rajiv Kumar (2017). Safinamide: A new add-on drug for the treatment of Parkinson's disease. JOURNAL OF MEDICAL COLLEGE CHANDIGARH, 7(2), 14-16. https://www.europub.co.uk/articles/-A-312495